Skip to main content
NeuronFeed

Recursion · Series B

Pioneering AI-driven solutions in drug discovery to radically improve lives.

Amount

$60M

Round

Series B

Valuation

—

Announced

May 2017

Investors

Lead investor

Lux Capital

Participating investors

Felicis Ventures Obvious Ventures Data Collective
📎 Source

Other Recursion rounds

Date Round Amount
Apr 2021 IPO $436.4M Details →
Sep 2020 Series D $239M Details →
Jul 2019 Series C $121M Details →